PRISM Mid-Day Movers: Board Shakeups and Biotech Financings Drive Investor Focus

2025-04-23 13:30:22 ET

Plus Therapeutics Climbs 35% After Biotech Finance Veteran Joins Board
Plus Therapeutics, Inc. ( PSTV ) jumped 34.66% to lead the PRISM Emerging Biotech Index following the appointment of Kyle Guse--a seasoned biotech executive and former Atossa Therapeutics CFO--to its Board of Directors . Guse will serve as Chair of the Audit Committee and a member of the Compensation Committee, bringing deep experience in legal, financial, and operational oversight to the clinical-stage radiotherapeutics company.

Guse's background spans executive leadership roles across NASDAQ-listed biotech and consumer companies, Big Four accounting, and top-tier corporate law. CEO Dr. Marc Hedrick welcomed the addition, stating, "Kyle's decades of experience will make an immediate and positive impact particularly as audit chair, he'll help drive stockholder value and execution of our business plan."

The move follows recent clinical progress with Plus' lead radiotherapeutic candidate REYOBIQ(TM), which targets aggressive central nervous system cancers like glioblastoma and leptomeningeal metastases.

Rezolute Advances 26% After Announcing $90M Financing with Institutional Backing
Rezolute, Inc. ( RZLT ), a part of the PRISM Emerging Biotech Index , rallied 25.72% midday after pricing a $90 million underwritten offering of common stock and pre-funded warrants . The raise, priced at-the-market, includes participation from well-known healthcare investors such as Blackstone Multi-Asset Investing, Federated Hermes Kaufmann Funds, Great Point Partners, and Marshall Wace--adding credibility and capital to fuel Rezolute's late-stage development programs.

Proceeds will support R&D, working capital, and general corporate purposes as Rezolute advances its pipeline, including ersodetug, an antibody therapy in development for all forms of hyperinsulinism (HI)--a rare but serious metabolic disorder. The company is targeting both congenital and tumor-related forms of HI, a space with high unmet need and limited competition.

Other PRISM Mid-Day Movers:

• Relmada Therapeutics, Inc. ( RLMD ) up 33.99%
• Maxeon Solar Technologies, Ltd. ( MAXN ) up 17.58%
• CommScope Holding Company, Inc. ( COMM ) up 14.71%
• Bannerman Energy Ltd. ( BNNLF ) up 16.48%

 

The post PRISM Mid-Day Movers: Board Shakeups and Biotech Financings Drive Investor Focus appeared first on PRISM MarketView .

COMTEX_464845322/2927/2025-04-23T12:30:22